Oncology Views & Analysis

Views & Analysis

Oncology

ASCO 2024 - Michael Petroutsas

Just two months into his new position as US president and head of commercial for Astellas, Michael Petroutsas joined pharmaphorum editor-in-chief Jonah Comstock for a conversation on the si

Oncology

Single-cell multi-omics and oncological potential

Just like people, no two cancer cells are alike.

Oncology

Top cancer types, trials, and AI innovations: What HCPs disc...

Kicking off in Chicago on the 31st May, the 2024 American Society of Clinical Oncology’s Annual Meeting - known as ASCO - welcomed more than forty thousand healthcare professionals through

Oncology

The fire and ice of oncolytic virotherapy

In the language of immuno-oncology (IO), the terms “hot” and “cold” refer to tumours that are inflamed or non-inflamed, respectively.

Oncology

Andree Amelsberg at ASCO 2024 and Jonah Comstock

ASCO 2024 - Andree Amelsberg

At ASCO 2024 last month, editor-in-chief Jonah Comstock caught up with Dr Andree Amelsberg, SVP of global and US medical affairs at Eisai, to chat about what the company was sharing at the

Oncology